Meet our speaker - Arsela Prelaj

Arsela Prelaj

Arsela Prelaj

Fondazione IRCCS Istituto Nazionale Tumori di Milano

Arsela Prelaj

Fondazione IRCCS Istituto Nazionale Tumori di Milano

Dzień 2
Moderated discussion
Rewolucja AI w ochronie zdrowia: równoważenie innowacji i odpowiedzialności
Health
13:20 - 13:40

BIO

She is a Consultant Medical Oncologist specializing in thoracic malignancies at the Thoracic Unit of Istituto Nazionale Tumori di Milano in Italy since 2018. She completed her residency in Medical Oncology at Sapienza University, Policlinico Umberto I Hospital in Rome, Italy. During her training, she was awarded the ESMO Clinical Unit Visit in 2017 and spent time at The Christie Hospital in Manchester in the Lung Cancer Division.

Over the past seven years, her research has primarily focused on thoracic malignancies, particularly non-small cell lung cancer (NSCLC) and translational immunotherapy. She recently earned a Ph.D. in Bioengineering and Artificial Intelligence from Politecnico di Milano.

She serves as the principal investigator for multiple international clinical trials and is actively involved in coordinating various national and international grant applications in the field of thoracic malignancies and immunotherapy. As the head of the AI-ON-Lab (Artificial Intelligence for Oncology Lab) at Istituto Nazionale Tumori of Milano, she is responsible for leading research and development in the application of AI in oncology.

Furthermore, she has been appointed as the Responsible for INT’s Research Line 4 program, which focuses on big data, clinical research, healthcare, and outcome research. She is an esteemed member of the ESMO Working Group on Real-World Data and Digital Health, and her expertise in AI has led to collaborations with ESMO starting in 2021.

She is leading many EU and National projects: I3LUNG, a 10-million project, APOLLO 11, BuonMarrow (4-million, Bone Marrow-on-Chip). She is PI of the SHAIPED EU project focus on health data body access. Finally, she is the President of the new founded European Interdisciplinary Society of AI in Cancer Research (ESAC).

She is an ESMO, ASCO, AACR, IASLC and AIOM member and faculty member at many congresses on AI.